American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,264 | 4,159 | 3,144 | 2,817 | 2,126 |
| Receivables | 2,738 | 2,375 | 2,998 | 1,762 | 1,701 |
| Inventories | 3,407 | 2,279 | 1,225 | 496 | 694 |
| Income taxes - deferred | 69 | 69 | 69 | 69 | 40 |
| Other current assets | 2,412 | 736 | 522 | 722 | 1,691 |
| TOTAL | $12,891 | $9,618 | $7,958 | $5,864 | $6,252 |
| Non-Current Assets | |||||
| PPE Net | 7,158 | 7,273 | 7,355 | 4,261 | 3,842 |
| Other Non-Current Assets | 678 | 693 | 708 | 723 | 741 |
| TOTAL | $7,836 | $7,966 | $8,063 | $4,984 | $4,582 |
| Total Assets | $20,727 | $17,584 | $16,021 | $10,848 | $10,834 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,776 | 946 | 957 | 582 | 829 |
| Other current liabilities | 214 | 815 | 572 | 336 | 291 |
| TOTAL | $4,829 | $3,485 | $3,211 | $2,413 | $2,642 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,829 | $3,485 | $3,211 | $2,413 | $2,642 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32 | 32 | 32 | 11 | 11 |
| Common Shares | 32 | 32 | 32 | 11 | 11 |
| Retained earnings | 7,529 | 6,285 | 4,996 | 3,826 | 3,571 |
| TOTAL | $15,898 | $14,099 | $12,809 | $8,435 | $8,192 |
| Total Liabilities And Equity | $20,727 | $17,584 | $16,021 | $10,848 | $10,834 |